Patients with spondyloarthrits in paid work may experience restrictions and difficulties while performing their job (i.e. presenteeism) and have to take sick leave (i.e. absenteeism). Eventually, many people have to stop working because of their arthritis. Loss of paid work contributes to a substantial economic burden for the individual and society, loss of work may also decrease quality of life and self-esteem of the individual patient with spondyloarthritis. This presentation will summarise the literature on the impact of spondyloarthritis on presenteeism and absenteeism and factors associated with these outcomes. Disclosures: The author has declared no conflicts of interest.
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I146 WHAT IS THE ROLE OF ULTRASOUND IN THE DIAGNOSIS OF CRYSTAL ARTHROPATHIES?
Richard Wakefield Osteogenesis imperfecta is a complex multisystem disorder characterised by bone fragility, frequent fractures and bony deformity, sarcopenia, ligamentous laxity and dilatation of the aortic root in later life. Bone material properties reflect increase tissue mineralisation density; at a cellular level, increased bone turnover is seen, although the driving mechanisms for this remain to be fully elucidated. Current pharmacological treatment approaches are based on slowing bone remodelling; emerging treatments may include bone anabolic agents, and agents targeting specific pathways that contribute to increased remodelling activity. The multidisciplinary team approach is key to improving the everyday quality of life of these patients and their families, and will remain so for the foreseeable future. Disclosures: The author has declared no conflicts of interest.
I150 THE YOUNGER PATIENT: A PAEDIATRIC RHEUMATOLOGY PERSPECTIVE OF CARE IN OSTEOGENESIS IMPERFECTA
Jaqui Clinch 1 1 Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UNITED KINGDOM This talk will cover our understanding, treatment, challenges and key research areas going forward when managing children and adolescents with osteogenesis imperfecta. Transition of these young people to adult services (where they are usually managed by rheumatology teams) will be covered and there will be time for discussion throughout. Disclosures: The author has declared no conflicts of interest.
I151 THE MANAGEMENT OF OSTEOGENESIS IMPERFECTA IN ADULTS
Ken Poole Chickenpox and shingles can be more severe and occasionally life threatening in immunosuppressed patients. As such, some groups warrant a more detailed history, serological testing and consideration of prophylaxis following contact with the virus. Active disease may also require more aggressive treatment with antivirals. Guidance for the use of varicella zoster immunoglobulin has recently been updated by Public Health England with important implications for rheumatology patients. The varicella and zoster vaccines are both live and therefore pose a small risk of vaccine strain disease in immunosuppressed patients. Identifying which patients to vaccinate and when poses a challenge for the rheumatologist. Disclosures: The author has declared no conflicts of interest. 
I153 VACCINATION BEYOND INFLUENZA AND PNEUMOCOCCUS

